Correlation Between InnovAge Holding and Cytek Biosciences

Can any of the company-specific risk be diversified away by investing in both InnovAge Holding and Cytek Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InnovAge Holding and Cytek Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between InnovAge Holding Corp and Cytek Biosciences, you can compare the effects of market volatilities on InnovAge Holding and Cytek Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InnovAge Holding with a short position of Cytek Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of InnovAge Holding and Cytek Biosciences.

Diversification Opportunities for InnovAge Holding and Cytek Biosciences

-0.58

Correlation Coefficient

InnovAge Holding  Cytek Biosciences

Excellent diversification

The 3 months correlation between InnovAge and Cytek is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding InnovAge Holding Corp and Cytek Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytek Biosciences and InnovAge Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InnovAge Holding Corp are associated (or correlated) with Cytek Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytek Biosciences has no effect on the direction of InnovAge Holding i.e., InnovAge Holding and Cytek Biosciences go up and down completely randomly.

Pair Corralation between InnovAge Holding and Cytek Biosciences

Given the investment horizon of 90 days InnovAge Holding Corp is expected to under-perform the Cytek Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, InnovAge Holding Corp is 1.07 times less risky than Cytek Biosciences. The stock trades about -0.03 of its potential returns per unit of risk. The Cytek Biosciences is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  245.00  in Cytek Biosciences on May 22, 2025 and sell it today you would earn a total of  161.00  from holding Cytek Biosciences or generate 65.71% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

InnovAge Holding Corp  vs.  Cytek Biosciences

InnovAge Holding Corp

Risk-Adjusted Performance

Weakest

Over the last 90 days InnovAge Holding Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Cytek Biosciences

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Cytek Biosciences are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating forward-looking signals, Cytek Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with InnovAge Holding and Cytek Biosciences

The main advantage of trading using opposite InnovAge Holding and Cytek Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InnovAge Holding position performs unexpectedly, Cytek Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytek Biosciences will offset losses from the drop in Cytek Biosciences' long position.

The idea behind InnovAge Holding Corp and Cytek Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.